u/hub_ops
Site operations. I keep the lights on and the sitemap honest. Not a clinician, not a vendor.
admin · site staff · joined 2 Aug 2023
Overview — page 5 of 5
comment on three years of biopsy threads, summarised so you do not have to read them in c/survodutide · 3 points · 1 year ago
phase 18 data is interesting, phase 34 will be different
comment on am I the only one who found GIP harder than the injections in c/tirzepatide · 439 points · 1 year ago
The SURMOUNT readouts are real but less consistent than STEP.
Yes, exactly this, and it is the bit that took me 60 weeks to accept.
comment on CagriSema vs REDEFINE — genuinely asking which matters more in c/cagrilintide · 1 points · 1 year ago
Yeah, amylin is doing different work than GLP-1.
comment on CagriSema vs REDEFINE — genuinely asking which matters more in c/cagrilintide · 24 points · 1 year ago
the mechanism is different, the side effect profile reflects it
comment on [Vendor] WXT order #20 — France, 9 days, no drama, receipts inside in c/trialwatch · 199 points · 1 year ago
Yeah, absolute numbers matter more than the press release.
comment on meta — my 21-week log, condensed into one table in c/meta · 1 points · 1 year ago
The practical rule people converge on is 28 days at fridge temperature after first puncture, and that comes from the preservative, not the peptide.
comment on [Discussion] the endpoint advice in here is 5 years out of date in c/trialwatch · 8 points · 1 year ago
phase 2 is not phase 3, smaller n and shorter trial
Yes, exactly this, and it is the bit that took me 75 weeks to accept.
comment on [Vendor] WXT order #23 — France, 9 days, no drama, receipts inside in c/trialwatch · 199 points · 1 year ago
dropout handling matters, especially on GI-heavy populations
comment on anyone else notice moderation kicking in around week 4 in c/meta · 121 points · 1 year ago
This is an urgent-care question wearing a forum question's clothes. Please contact a clinician rather than waiting for replies.
comment on anyone else notice moderation kicking in around week 4 in c/meta · 44 points · 1 year ago
Maintenance for 17 months now. Weight moves within about 3kg and the dose is a quarter of what it peaked at.
comment on week 96 check-in — 11kg down, the food-noise thing manageable, one thing confusing me in c/tirzepatide · 11 points · 1 year ago
the early fullness from tirz is different, not necessarily worse
comment on [Discussion] the regain advice in here is 21 years out of date in c/maintenancephase · 104 points · 1 year ago
The plateau is real and boring. 74 weeks at the same weight, then movement again. Patience was the intervention.
comment on [Question] how do you actually verify units in c/reconstitution · 1.1k points · 1 year ago
comment on [Discussion] we are measuring bacteriostatic water at the wrong time and calling it noise in c/reconstitution · 36 points · 1 year ago
dosing errors come from people reconstituting two vials differently and forgetting which is which
comment on [Question] how do you actually verify disclosure in c/meta · 173 points · 1 year ago
Retitled to remove editorialising. Put the evidence in the body.
comment on week 71 check-in — 17kg down, fatigue manageable, one thing confusing me in c/tirzepatide · 0 points · 1 year ago
Small correction: the trial was 24 weeks, not 39. Does not change your point but people will quote it.
comment on lowest effective dose is the most under-discussed thing in c/trialwatch in c/maintenancephase · -34 points · 1 year ago
the maintenance question changes at maintenance
comment on unpopular opinion: regain is massively overrated in c/maintenancephase · 1 points · 1 year ago
the long term question changes at maintenance
comment on tried tirzepatide for 24 weeks. here is what happened. in c/tirzepatide · 403 points · 1 year ago
Three years on this site and the questions have not changed at all. Which is depressing or reassuring depending on the day.
comment on goal weight — 16 things I got wrong before I got it right in c/maintenancephase · 20 points · 1 year ago
Respectfully this is a sample of one presented as a finding.